Research use retatrutide peptide for laboratory studies of GIP, GLP-1, and glucagon receptor activity and related metabolic signaling.
| Feature | Details |
| Product Name | Retatrutide 10mg |
| Supplier | Hemi Pharma |
| Active Compound | Retatrutide (LY3437943) |
| Research Classification | Research Use Only (RUO) |
| Peptide Type | Synthetic peptide |
| Receptor Activity | GIP, GLP-1, and glucagon receptor agonist |
| Research Areas | Hormone receptor activity, metabolic signaling, and related cellular processes |
| Quantity | 10mg |
£69.00
Smart Packaging
Secure Payment
14-Day Returns
Retatrutide 10mg by Hemi Pharma is a research-grade peptide provided for laboratory research and experimental applications. Also known as LY3437943, retatrutide is an investigational peptide that interacts with three hormone receptors. GIP, GLP-1, and glucagon.
Researchers study retatrutide to learn how these receptor systems work together and how their activity relates to hormone signaling and metabolism. This makes it relevant to laboratory investigations involving receptor activity, cellular signaling, and related molecular functions. The 10mg quantity is sufficient research material for these investigations.
£41.00
£120.00
£34.00
